Gene · 2046
Papers2,828
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 2,828
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Engineered lentivirus-derived nanoparticles (LVNPs) for delivery of CRISPR/Cas ribonucleoprotein complexes supporting base editing, prime editing and in vivo gene modification. | Nucleic Acids Res | 2023 | 37678882 | PubTator, text mining | PubMed |
| Research progress on the anti-tumor effect of Naringin. | Front Pharmacol | 2023 | 37663256 | PubTator, text mining | PubMed |
| Phage-assisted evolution and protein engineering yield compact, efficient prime editors. | Cell | 2023 | 37657419 | PubTator, text mining | PubMed |
| Construction of lncRNA-miRNA-mRNA regulatory network in severe asthmatic bronchial epithelial cells: A bioinformatics study. | Medicine (Baltimore) | 2023 | 37657025 | PubTator, text mining | PubMed |
| Salivary Soluble CD44 Level in Chronic Periodontitis - A Comparative Assessment between Preoperative and Postoperative Scaling and Root Planing. | J Pharm Bioallied Sci | 2023 | 37654413 | PubTator, text mining | PubMed |
| A network pharmacology and molecular docking investigation on the mechanisms of Shanyaotianhua decoction (STT) as a therapy for psoriasis. | Medicine (Baltimore) | 2023 | 37653756 | PubTator, text mining | PubMed |
| Exploring the multi-gene regulatory molecular mechanism of Saudi Arabian flora against epilepsy based on data mining, network pharmacology and docking analysis. | Saudi Pharm J | 2023 | 37638220 | PubTator, text mining | PubMed |
| Eph receptor B6 shapes a cold immune microenvironment, inhibiting anti-cancer immunity and immunotherapy response in bladder cancer. | Front Oncol | 2023 | 37637034 | PubTator, text mining | PubMed |
| SASH1: A Novel Eph Receptor Partner and Insights into SAM-SAM Interactions. | J Mol Biol | 2023 | 37619706 | PubTator, text mining | PubMed |
| The potential effect and mechanism of Saikosaponin A against gastric cancer. | BMC Complement Med Ther | 2023 | 37608281 | PubTator, text mining | PubMed |
| Evidence- and data-driven classification of low back pain via artificial intelligence: Protocol of the PREDICT-LBP study. | PLoS One | 2023 | 37603539 | PubTator, text mining | PubMed |
| Single-cell genomics improves the discovery of risk variants and genes of atrial fibrillation. | Nat Commun | 2023 | 37591828 | PubTator, text mining | PubMed |
| PINE-TREE enables highly efficient genetic modification of human cell lines. | Mol Ther Nucleic Acids | 2023 | 37588683 | PubTator, text mining | PubMed |
| Obtaining Functional Proteomics Insights From Thermal Proteome Profiling Through Optimized Melt Shift Calculation and Statistical Analysis With InflectSSP. | Mol Cell Proteomics | 2023 | 37562535 | PubTator, text mining | PubMed |
| Reprogramming human B cells with custom heavy chain antibodies. | Res Sq | 2023 | 37503066 | PubTator, text mining | PubMed |
| Low-dose apatinib in subjects with renal impairment: A pharmacokinetics study. | Eur J Pharm Sci | 2023 | 37490973 | PubTator, text mining | PubMed |
| Rapid Analytical Method Development and Validation of RP-HPLC Method for the Simultaneous Estimation of Exemestane and Genistein with Specific Application in Lipid-Based Nanoformulations. | ACS Omega | 2023 | 37483215 | PubTator, text mining | PubMed |
| Changes in social behavior with MAPK2 and KCTD13/CUL3 pathways alterations in two new outbred rat models for the 16p11.2 syndromes with autism spectrum disorders. | Front Neurosci | 2023 | 37465586 | PubTator, text mining | PubMed |
| An Overview of EGFR Mechanisms and Their Implications in Targeted Therapies for Glioblastoma. | Int J Mol Sci | 2023 | 37446288 | PubTator, text mining | PubMed |
| Identification of Genetic Risk Factors for Keratinocyte Cancer in Immunosuppressed Solid Organ Transplant Recipients: A Case-Control Study. | Cancers (Basel) | 2023 | 37444464 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2046/papers?page=6